MREO
Mereo BioPharma GroupCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
MREO vs peer average
69/100
MREO vs. peer average (C vs. D)
Grade spread
A 1 · C 1 · D 2 · F 6
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ALGS is the first available peer comparator.
Aligos is a loose same-cap clinical biotech comparator where valuation is also driven more by milestone timing and funding capacity than by current revenue.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MREO
Mereo BioPharma Group
ALGS
Aligos Therapeutics
Grade
C
A
Momentum
91
65
Value
42
57
Sentiment
24
64
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs ALGS
MREO / ALGS
Grade Position
In line
MREO vs. peer average (C vs. D)
69/100
Momentum
91
MREOValue
42
ALGSSentiment
24
ALGSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MREO
ALGS is the first peer returned for this comparison set.